Every disclosed congressional trade in REGENERON PHARMACEUTICALS, INC. (REGN) — self-reported under the STOCK Act, straight from the House Clerk and Senate eFD — carried alongside our independent SEC-grounded rating on the same stock.
Self-reported Periodic Transaction Reports (STOCK Act). Amounts are disclosed ranges, never exact; a member's filing may cover a spouse's trade; disclosures lag the trade by up to ~45 days. Our Buy/Hold/Sell verdict is an independent SEC-grounded rating of REGN — not a view on any member's trade, and not investment advice. Source: House Clerk + Senate eFD.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.